Skip to main content

Enrollment in the Health Benefits for Immigrant Adults (HBIA) program will be temporarily paused effective July 1, 2023.

Enrollment in the Health Benefits for Immigrant Seniors (HBIS) program will be temporarily paused effective Nov. 6, 2023.

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: March 14, 2012

Drug Name Review Type Class Manufacturer
Juvisync New Drug Initial Review Diabetes/Cholesterol Merck and Co. Inc
Eylea New Drug Initial Review VEGF Inhibitor Regeneron
Pedipirox-4 Nail Kit New Drug Initial Review Antifungal � Topical Pedinol
Complera New Drug Appeal HIV Gilead
Natroba New Drug Appeal Pediculicide ParaPRO, LLC